FDA rejects Corcept’s rare hormonal disorder drug
The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal disorder, the company said on Wednesday. Shares of the drugmaker…
Novo Nordisk stock jumps 7.5% after FDA approves weight-loss pill
Novo Nordisk shares rose 7.5% in early trading on Tuesday after the U.S. Food and Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge in the…
FDA approved Novo Nordisk’s weight-loss pill
The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for…
FDA fast-tracks approval of six Altria-owned on! PLUS nicotine pouches
The U.S. Food and Drug Administration said on Friday it has authorized the marketing of six Altria-owned on! PLUS nicotine pouch products, through a pilot program aimed to fast-track reviews…